Skip to main content
Clinical Trials/NCT00709813
NCT00709813
Completed
N/A

Including Patient Preferences in Symptom Management of Cancer Patients: A Randomized Clinical Trial

Oslo University Hospital0 sites145 target enrollmentDecember 2003

Overview

Phase
N/A
Intervention
Not specified
Conditions
Cancer
Sponsor
Oslo University Hospital
Enrollment
145
Primary Endpoint
Physicians' and nurses' symptom-related chart entries in patients' records
Status
Completed
Last Updated
14 years ago

Overview

Brief Summary

Patient-provider shared decision making and the inclusion of patients' illness experiences and preferences in patient care are prioritized areas in health care. CHOICE is a computer-based support system for patient-centered symptom management of cancer patients developed for this purpose. In this randomized clinical trial at Rikshospitalet- Radiumhospitalet HF 145 adult stem-cell transplantation and newly diagnosed lymphoma and leukemia patients used CHOICE for assessments of their symptoms, problems and priorities for care at in-and outpatient visits during treatment and rehabilitation. In the experimental group this information was shared with physicians an nurses for subsequent care planning, but not in the control group.

This study tested effects of CHOICE on symptom- related patient care and outcomes of symptom relief, patients' needs for care over time and patient satisfaction;(2) analyzed how patients' symptoms, needs for care varied during illness/treatment stages; and (3) evaluated CHOICE' ease of use and user satisfaction. Controlling for gender, age, diagnosis, and type/stage of treatment, education, depression, health related quality of life, and social support, repeated measurement models were used to test differences and variations in outcome variables within and between groups and over time.

Detailed Description

as above

Registry
clinicaltrials.gov
Start Date
December 2003
End Date
December 2005
Last Updated
14 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Oslo University Hospital

Eligibility Criteria

Inclusion Criteria

  • Starting treatment for a newly diagnosed acute myelogenous leukemia (AML), lymphatic leukemia (ALL), Hodgkin or non-Hodgkin lymphoma, or
  • starting treatment for a recurrence of the disease;
  • starting treatment with allogenous or autologous Stem Cell Transplantation (SCT).
  • above 18 years of age.

Exclusion Criteria

  • having received radiation on the brain

Outcomes

Primary Outcomes

Physicians' and nurses' symptom-related chart entries in patients' records

Time Frame: In-patient episodes of care

Symptom distress over time

Time Frame: Repeated episodes of care

Patients' prioritized needs for care over time

Time Frame: Repeated episodes of care

Secondary Outcomes

  • Patient satisfaction(End of study)
  • Care providers' satisfaction(End of study)
  • Preferences for participation in decision making- and changes over time(Baseline, and at completion of treatment)

Similar Trials